跳至主要内容
临床试验/EUCTR2005-004646-13-IT
EUCTR2005-004646-13-IT进行中(未招募)不适用

PEG-Filgrastim versus Filgrastim as an adjunct to therapy CHOP-14 Rituximab in elderly patients 60-75 years old with B cell non-Hodgkin s High/intermediate grade lymphoma. A randomized, prospectic, multicenter, open-label, phase II study.

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点目标入组 50 人开始时间: 2007年4月13日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

相似试验

PEG-Filgrastim versus Filgrastim as an adjunct to... | 临床试验